12 January 2022

Inter-reader variability can create challenges in oncology trial results. During this 45-minute webinar, Median Technologies will address the 4 main causes of variability occurring during RECIST1.1 assessment and describe control strategies using data analytics and medical investigations. During this presentation, you will:

  • Discover the most common types of reader discrepancies in oncology follow-up
  • Learn how to control the causes of variability in centralized independent review and how to prevent them
  • Grasp how we at Median Technologies, handle inter-reader variability through our methods and strategies

Presenters

  • Antoine Iannessi, Medical Director, Median Technologies
  • Emilie Serres, Clinical Research Scientist, Median Technologies